Canopy Growth CorpCGC

NasdaqHealthcareMedicinal Chemicals & Botanical Products
Price (close)
$0.94
Market cap
$398.5M
P/E
—
Revenue (TTM)
$293.6M
Net income
-$232.6M
Dividend yield
—
1-year total return
-31.2%
Net margin
-79.2%
Revenue growth
6.8%
Debt / equity
0.35x

What Canopy Growth Corp does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202120222023202420252026
Revenue$546.6M$475.7M$333.3M$297.1M$269.0M$284.6M
Net income-$1.7B-$310.0M-$3.3B-$693.7M-$508.9M-$262.9M
Free cash flow-$630.2M-$582.5M-$566.7M-$285.4M-$176.6M-$69.1M

More on CGC.

Figures from Canopy Growth Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.